Blog
Month: February 2020

Quality Management Systems for advanced therapies, Part 1: the essentials

Blog

Note: this post is the first in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management)...

Quality Management Systems for advanced therapies, Part 2: six areas of focus

Blog

Note: this post is the second in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management)...

Data management for advanced therapies, Part 8: the benefits of a strategic approach

Blog

Note: this post is the eighth in an eight-part series on data management strategies for personalized therapeutics, such as cell...

Data management for advanced therapies, Part 7: summing up the strategies

Blog

Note: this post is the seventh in an eight-part series on data management strategies for personalized therapeutics, such as cell...

Data management for advanced therapies, Part 6: efficiencies across the supply chain

Blog

Note: this post is the sixth in an eight-part series on data management strategies for personalized therapies, such as cell...

Data management for advanced therapies, Part 5: traceability

Blog

Note: this post is the fifth in an eight-part series on data management strategies for personalized therapies, such as cell...

Our Series C and the road ahead

Blog

Today, we announced Vineti’s $35 million Series C round of investment. A first-of-its-kind investor coalition of industry leaders — Cardinal Health,...